The only current objective study of executive compensation in the industry, providing a detailed picture of compensation packages at 224 publicly traded biotech companies.

Published by the editors of BioWorld Today, the newspaper of record for the biotechnology industry, the new BioWorld Executive Compensation Report 2010, provides you with a variety of perspectives on compensation issues by means of key statistics and graphic analyses.

With the BioWorld Executive Compensation Report 2010, you will be able to:

• Determine where you rank among your peers in terms of compensation packages!
• Look-up exact dollar amounts of individual salaries, bonuses, and stock options!
• Analyze data on salary increases from the prior year!
• Reference dozens of charts, tables, and graphs to illustrate executive compensation in the biotech industry!

This updated report offers an in-depth look at executive compensation at biotechnology companies by providing extensive details on individual salary packages, as well as expert analysis and interpretation on compensation trends within the industry.

Companies of every size across the full range of research sectors — from new public companies to industry giants — are covered, using a variety of rankings and comparative listings along with detailed information concerning each company.

The BioWorld Executive Compensation Report 2010 also provides you with complete salary, bonus, and market capitalization data and rankings of six top-level job titles:

• Chief Executive Officers
• Chief Financial Officers
• Chief Operating Officers
• VPs of Research and Development
• Chief Legal Officers
• Heads of Business/Corporate Development